| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 182 | 2022 |
| The NAFLD‐MAFLD debate: eminence vs evidence Y Fouad, R Elwakil, M Elsahhar, E Said, S Bazeed, A Ali Gomaa, ... Liver International 41 (2), 255-260, 2021 | 90 | 2021 |
| The effectiveness and safety of ledipasvir plus sofosbuvir in adolescents with chronic hepatitis C virus genotype 4 infection: a real‐world experience HR El‐Khayat, EM Kamal, MH El‐Sayed, M El‐Shabrawi, H Ayoub, ... Alimentary pharmacology & therapeutics 47 (6), 838-844, 2018 | 47 | 2018 |
| Sofosbuvir plus daclatasvir with or without ribavirin in 551 patients with hepatitis C‐related cirrhosis, genotype 4 H El‐Khayat, Y Fouad, HI Mohamed, H El‐Amin, EM Kamal, M Maher, ... Alimentary pharmacology & therapeutics 47 (5), 674-679, 2018 | 43 | 2018 |
| Primary Sjögren’s syndrome and B-non-Hodgkin lymphoma: role of CD4+ T lymphocytopenia F Ismail, A Mahmoud, H Abdelhaleem, A Mamdoh, M Geneidy, E Kamal Rheumatology international 33, 1021-1025, 2013 | 33 | 2013 |
| A pilot single arm observational study of sofosbuvir/ledipasvir (200+ 45 mg) in 6‐to 12‐year old children MHF El‐Shabrawi, NM Kamal, HR El‐Khayat, EM Kamal, M AbdElgawad, ... Alimentary pharmacology & therapeutics 47 (12), 1699-1704, 2018 | 32 | 2018 |
| Clinical significance and diagnostic value of serum dickkopf-1 in patients with hepatocellular carcinoma YM Fouad, HI Mohamed, EM Kamal, MA Rasek Scandinavian journal of gastroenterology 51 (9), 1133-1137, 2016 | 28 | 2016 |
| The egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease Y Fouad, G Esmat, R Elwakil, S Zakaria, A Yosry, I Waked, M El-Razky, ... Saudi Journal of Gastroenterology 28 (1), 3-20, 2022 | 24 | 2022 |
| Effectiveness of 8-week sofosbuvir/ledipasvir in the adolescent chronic hepatitis C-infected patients H El-Khayat, EM Kamal, M Yakoot, MA Gawad, N Kamal, M El Shabrawi, ... European journal of gastroenterology & hepatology 31 (8), 1004-1009, 2019 | 20 | 2019 |
| Effects of sofosbuvir/ledipasvir therapy on chronic hepatitis C virus genotype 4, infected children of 3‐6 years of age EM Kamal, M El‐Shabrawi, H El‐Khayat, M Yakoot, Y Sameh, Y Fouad, ... Liver International 40 (2), 319-323, 2020 | 19 | 2020 |
| Effects of dual sofosbuvir/daclatasvir therapy on, chronic hepatitis C infected, survivors of childhood malignancy MHF El-Shabrawi, LM Sherief, M Yakoot, NM Kamal, MA Almalky, ... World journal of clinical cases 7 (16), 2247, 2019 | 15 | 2019 |
| Expression of proteinase-activated receptor-2 in the esophageal mucosa of gastroesophageal reflux disease patients: a histomorphologic and immunohistochemical study DM Abd El-Rehim, HKF El-Bab, EM Kamal Applied Immunohistochemistry & Molecular Morphology 23 (9), 646-652, 2015 | 10 | 2015 |
| Validity of c-reactive protein and procalcitonin in the prediction of bacterial infection in patients with liver cirrhosis EM Kamal, MA Abd EL-Hakeem, AM El Sayed, MM Ahmed Minia Journal of Medical Research 30 (3), 124-127, 2019 | 8 | 2019 |
| Treatment of chronic hepatitis C in adolescent patients with positive HBsAg or with occult hepatitis B: is the risk of hepatitis B reactivation significant? H El-Khayat, M Yakoot, M El-Shabrawi, Y Fouad, D Attia, EM Kamal The Pediatric infectious disease journal 40 (1), 11-15, 2021 | 7 | 2021 |
| Non-invasive Evaluation of Liver Fibrosis Changes in Patients with Chronic Hepatitis C after Directly Acting Antiviral Drugs TM Hassanin, H Ibraheem, M Makhlouf, W Mahmoud, N El-Ameen, ... Afro-Egyptian Journal of Infectious and Endemic Diseases 12 (1), 92-98, 2022 | 2 | 2022 |
| Retreatment of chronic hepatitis C virus genotype-4 patients after non-structural protein 5A inhibitors' failure: efficacy and safety of different regimens H El-Khayat, EM Kamal, H Mahmoud, A Gomaa, B Ebeid, Y Sameh, ... European Journal of Gastroenterology & Hepatology 32 (3), 440-446, 2020 | 1 | 2020 |
| Effect of Direct-Acting Antivirals on Lipid and Glucose Metabolism in Chronic HCV Patients EM Kamal, AM El-Sayed, MA Mohammed Minia Journal of Medical Research 30 (3), 120-123, 2019 | 1 | 2019 |
| Effects of dual sofosbuvir/daclatasvir therapy on weight and linear growth in adolescent patients with chronic hepatitis C virus infection M Yakoot, MH El-Shabrawi, MM AbdElgawad, AA Mahfouz, AF Khalil, ... The Pediatric Infectious Disease Journal 38 (7), e154-e157, 2019 | 1 | 2019 |
| Leucocyte Esterase Reagent (LER) Strips: a Rapid, Easy, and Cheap Test for the Diagnosis of Spontaneous Bacterial Peritonitis. E Kamal, H Abdelhaleem MJMR 24 (1), 1-6, 2013 | 1 | 2013 |
| MAFLD vs. MASLD: consensus is unlike evidence! E Kamal, AM Mostafa, Y Fouad Annals of hepatology, 101527, 2024 | | 2024 |
